ADAGENE INC-ADR (ADAG:NASDAQ)

$2.49 0.08 (3.3195%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 75

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ADAGENE INC-ADR (ADAG:NASDAQ) News Sources

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

02-04-2026

yahoo.com

Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

17-04-2026

yahoo.com

Adagene Spotlights ADG126 Strategy as Masked CTLA-4 Trial Advances in Colorectal Cancer

19-05-2026

marketbeat.com

Adagene (ADAG) Upgraded to Buy: Here's What You Should Know

05-06-2026

yahoo.com

Adagene to Participate in Three Upcoming Investor Conferences

20-08-2026

yahoo.com

Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

10-09-2026

yahoo.com

Adagene Announces NMPA Clearance of Investigational New Drug Application for ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager

22-09-2026

yahoo.com

Adagene to Participate in H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference

14-10-2026

yahoo.com

Adagene Highlights SAFEbody Pipeline, ADG138 Clinical Launch and 2027 Catalysts

16-10-2026

marketbeat.com

Adagene Eyes Phase II Data for Masked CTLA-4 Therapy in MSS Colorectal Cancer

25-10-2026

marketbeat.com

ADAGENE INC-ADR (ADAG:NASDAQ) Sentiment Trend

0 25 50 75 100 64 64 87 90 74 73 60 84 89 63 02-04-2026 17-04-2026 19-05-2026 05-06-2026 20-08-2026 10-09-2026 22-09-2026 14-10-2026 16-10-2026 25-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ADAGENE INC-ADR (ADAG:NASDAQ) FAQs

toggle

What is the current price of ADAGENE INC-ADR (ADAG:NASDAQ)?

The current price of ADAGENE INC-ADR (ADAG:NASDAQ) is $2.49.


toggle

ADAGENE INC-ADR (ADAG:NASDAQ) absolute price change since previous trading day?

The absolute price change of ADAGENE INC-ADR (ADAG:NASDAQ) since the previous trading day is $0.08.


toggle

ADAGENE INC-ADR (ADAG:NASDAQ) percentage price change since previous trading day?

The percentage price change of ADAGENE INC-ADR (ADAG:NASDAQ) since the previous trading day is 3.3195%.


toggle

What is the most recent average sentiment score for ADAGENE INC-ADR (ADAG:NASDAQ)?

The most recent average sentiment score for ADAGENE INC-ADR (ADAG:NASDAQ) is 75 out of 100.


toggle

What is the most recent average sentiment for ADAGENE INC-ADR (ADAG:NASDAQ)?

The most recent sentiment for ADAGENE INC-ADR (ADAG:NASDAQ) is .


SEC-8K** Filing Available For ADAGENE INC-ADR (ADAG:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.